NM_001101362.3:c.15dupA
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_001101362.3(KBTBD13):c.15dupA(p.Gln6ThrfsTer139) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101362.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KBTBD13 | NM_001101362.3 | c.15dupA | p.Gln6ThrfsTer139 | frameshift_variant | Exon 1 of 1 | ENST00000432196.5 | NP_001094832.1 | |
RASL12 | NM_001379429.1 | c.-232dupT | upstream_gene_variant | NP_001366358.1 | ||||
RASL12 | XM_011521660.4 | c.-281dupT | upstream_gene_variant | XP_011519962.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
The c.15dupA variant in the KBTBD13 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.15dupA variant causes a frameshift starting with codon Glutamine 6, changes this amino acid to a Threonine residue, and creates a premature Stop codon at position 139 of the new reading frame, denoted p.Gln6ThrfsX139. This variant is predicted to cause loss of normal protein function through protein truncation, however, loss-of-function is not an established mechanism of disease for the KBTBD13 gene. The c.15dupA variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.15dupA as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at